We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

229 hedge funds and large institutions have $188M invested in Editas Medicine in 2024 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 68 increasing their positions, 64 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more call options, than puts

Call options by funds: $1.5M | Put options by funds: $1.14M

6% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 64

1.71% less ownership

Funds ownership: 68.57% → 66.86% (-1.7%)

3% less funds holding

Funds holding: 235 → 229 (-6)

12% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 41

29% less capital invested

Capital invested by funds: $263M → $188M (-$75.6M)

Holders
229
Holders Change
-6
Holders Change %
-2.55%
% of All Funds
3.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
36
Increased
68
Reduced
64
Closed
41
Calls
$1.5M
Puts
$1.14M
Net Calls
+$362K
Net Calls Change
-$415K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$3.88M
2
Two Sigma Investments
Two Sigma Investments
New York
+$3.56M
3
APM
Avidity Partners Management
Texas
+$2.83M
4
Jane Street
Jane Street
New York
+$2.5M
5
CSS
Cubist Systematic Strategies
Connecticut
+$2.05M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$9.27M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$5.89M
3
DTC
Deep Track Capital
Connecticut
-$4.79M
4
IHAM
Integral Health Asset Management
New York
-$3.15M
5
Squarepoint
Squarepoint
New York
-$2.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
GI
201
GAMMA Investing
California
$467 -$6.01K -1,381 -91%
TWD
202
True Wealth Design
Ohio
$410 +$522 +120 New
M
203
MOTCO
Texas
$375 – – –
NRG
204
Nemes Rush Group
Michigan
$371 – – –
PMFA
205
Plante Moran Financial Advisors
Michigan
$341 – – –
VAMG
206
Voisard Asset Management Group
Michigan
$341 – – –
VCM
207
Versant Capital Management
Arizona
$341 +$435 +100 New
BHWM
208
Beaird Harris Wealth Management
Texas
$273 – – –
KFI
209
Key Financial Inc
Pennsylvania
$256 – – –
CFGS
210
Concourse Financial Group Securities
Alabama
$255 – – –
BLC
211
Brown, Lisle/Cummings
Rhode Island
$222 – – –
MBFW
212
Morton Brown Family Wealth
Pennsylvania
$222 – – –
Northwestern Mutual Wealth Management
213
Northwestern Mutual Wealth Management
Wisconsin
$208 +$261 +60 +6,000%
TC
214
Truvestments Capital
Florida
$208 +$266 +61 New
PA
215
Parallel Advisors
California
$205 -$762 -175 -74%
DIP
216
DT Investment Partners
Pennsylvania
$185 +$235 +54 New
CFFP
217
Center for Financial Planning
Michigan
$171 – – –
GWP
218
Gen-Wealth Partners
Michigan
$160 – – –
NSIM
219
North Star Investment Management
Illinois
$130 – – –
CTA
220
Colonial Trust Advisors
South Carolina
$102 – – –
CA
221
Clearstead Advisors
Ohio
$86 – – –
RIL
222
Rothschild Investment LLC
Illinois
$85 – – –
HI
223
Harbour Investments
Wisconsin
$65 – – –
GWSG
224
GPS Wealth Strategies Group
Colorado
$27 +$9 +2 +33%
PCMC
225
Planning Capital Management Corporation
Pennsylvania
$24 – – –
7 8
9
10 11

EDIT Hedge Fund Activity: Q3 2024 in Review

229 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2024, worth a combined $188M — down 29% from $263M a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of EDIT and 36 opened new positions — a net loss of 5 holders — while 64 trimmed existing stakes and 68 added.

The largest buyer was Millennium Management, adding an estimated $3.88M. The largest seller was State Street, cutting an estimated $9.27M.

  • 229 institutional investors held Editas Medicine (EDIT) as of Q3 2024, down from 235 in Q2 2024.
  • Funds reported $188M of Editas Medicine stock for Q3 2024, down 29% quarter-over-quarter.
  • 36 funds opened new Editas Medicine positions in Q3 2024 and 41 closed out, a net change of -5 holders.
  • The largest Editas Medicine buyer in Q3 2024 was Millennium Management, an estimated $3.88M added.
  • The largest Editas Medicine seller in Q3 2024 was State Street, an estimated $9.27M sold.

Based on aggregated 13F filings for Q3 2024.